Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells
- PMID: 16391791
Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells
Abstract
To clarify the potential involvement of plasmin(ogen) cascade proteins in the cell dissociation and subsequent invasion of pancreatic cancer cells, western blot analysis, immunocytochemistry, immunohistochemistry, and in vitro invasion assay were performed in the cell lines or tissue of pancreatic cancer. The strong expression of plasmin(ogen), urokinase type plasminogen activator (uPA) and uPA receptor (uPAR), and apparently weak expression of the relevant proteins were found in the conditioned medium of dissociated (PC-1.0) and non-dissociated (PC-1) pancreatic cancer cells, respectively. Furthermore, uPA-treatment significantly induced the expression of plasmin(ogen) and uPAR in the conditioned medium of non-dissociated (PC-1) pancreatic cancer cells. Moreover, the expression of plasmin(ogen) and uPAR was stronger at the invasive front than at the center of human pancreatic cancer tissue. On the other hand, plasmin-treatment induced the expression of matrix metalloproteinase-2 (MMP-2), MMP-7 and MMP-9 in PC-1 cells. Simultaneously, plasmin- or uPA-treatments obviously induced the dissociation of cell colonies and in vitro invasiveness in PC-1 cells. The plasmin(ogen) cascade is closely involved in the invasion of pancreatic cancer cells and, especially in its early stage, cell dissociation. Targeting the plasmin(ogen) cascade may provide a new insight into molecular target therapy based on anti-invasion and anti-metastasis for pancreatic cancer.
Similar articles
-
Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.Clin Cancer Res. 2007 Jun 1;13(11):3115-24. doi: 10.1158/1078-0432.CCR-06-2088. Clin Cancer Res. 2007. PMID: 17545513
-
Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.Int J Oncol. 2005 May;26(5):1283-9. Int J Oncol. 2005. PMID: 15809719
-
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.Cancer Res. 2005 Sep 1;65(17):7775-81. doi: 10.1158/0008-5472.CAN-05-0946. Cancer Res. 2005. PMID: 16140945
-
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S46-58. doi: 10.1097/01.blo.0000093845.72468.bd. Clin Orthop Relat Res. 2003. PMID: 14600592 Review.
-
Plasmin/plasminogen system in colorectal cancer.World J Surg. 2002 Jul;26(7):767-71. doi: 10.1007/s00268-002-4050-8. Epub 2002 Apr 30. World J Surg. 2002. PMID: 11965442 Review.
Cited by
-
Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis.Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):25-35. doi: 10.1016/j.cytogfr.2012.01.003. Epub 2012 Feb 16. Cytokine Growth Factor Rev. 2012. PMID: 22342309 Free PMC article. Review.
-
Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.Mol Cancer. 2009 Oct 21;8:88. doi: 10.1186/1476-4598-8-88. Mol Cancer. 2009. PMID: 19845941 Free PMC article.
-
Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor.Pharmacology. 2009;84(5):271-5. doi: 10.1159/000242997. Epub 2009 Oct 1. Pharmacology. 2009. PMID: 19797936 Free PMC article.
-
Association of Fibrinolytic Potential and Risk of Mortality in Cancer Patients.Cancers (Basel). 2023 Sep 3;15(17):4408. doi: 10.3390/cancers15174408. Cancers (Basel). 2023. PMID: 37686683 Free PMC article.
-
Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis.ERJ Open Res. 2022 Oct 24;8(4):00191-2022. doi: 10.1183/23120541.00191-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36299365 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous